HomeCompareSBTX vs JEPQ

SBTX vs JEPQ: Dividend Comparison 2026

SBTX yields 34.07% · JEPQ yields 11.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBTX wins by $121.2K in total portfolio value
10 years
SBTX
SBTX
● Live price
34.07%
Share price
$5.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$24,647.82
Full SBTX calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.47%
Share price
$53.77
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.8K
Annual income
$2,269.18
Full JEPQ calculator →

Portfolio growth — SBTX vs JEPQ

📍 SBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBTXJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBTX + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBTX pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX
Annual income on $10K today (after 15% tax)
$2,896.08/yr
After 10yr DRIP, annual income (after tax)
$20,950.65/yr
JEPQ
Annual income on $10K today (after 15% tax)
$974.55/yr
After 10yr DRIP, annual income (after tax)
$1,928.80/yr
At 15% tax rate, SBTX beats the other by $19,021.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + JEPQ for your $10,000?

SBTX: 50%JEPQ: 50%
100% JEPQ50/50100% SBTX
Portfolio after 10yr
$106.4K
Annual income
$13,458.50/yr
Blended yield
12.65%
📊

Analyst Conviction Gap

Where Wall Street is split right now

SBTX
Analyst Ratings
5
Hold
Consensus: Hold
Altman Z
-0.3
Piotroski
1/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys
0
JEPQ buys
0
No recent congressional trades found for SBTX or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBTXJEPQ
Forward yield34.07%11.47%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$167.0K$45.8K
Annual income after 10y$24,647.82$2,269.18
Total dividends collected$119.3K$17.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SBTX vs JEPQ ($10,000, DRIP)

YearSBTX PortfolioSBTX Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$14,107$3,407.16$11,967$1,146.53+$2.1KSBTX
2$19,587$4,492.08$14,216$1,268.02+$5.4KSBTX
3$26,787$5,828.90$16,774$1,392.20+$10.0KSBTX
4$36,112$7,450.06$19,667$1,518.21+$16.4KSBTX
5$48,026$9,386.56$22,925$1,645.21+$25.1KSBTX
6$63,055$11,666.79$26,578$1,772.40+$36.5KSBTX
7$81,784$14,315.54$30,656$1,899.04+$51.1KSBTX
8$104,862$17,353.02$35,194$2,024.45+$69.7KSBTX
9$132,997$20,794.11$40,228$2,148.01+$92.8KSBTX
10$166,954$24,647.82$45,796$2,269.18+$121.2KSBTX

SBTX vs JEPQ: Complete Analysis 2026

SBTXStock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this SBTX vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHDSBTX vs JEPISBTX vs OSBTX vs KOSBTX vs MAINSBTX vs XYLDSBTX vs QYLDSBTX vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.